These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24680736)

  • 1. Double deletion of orexigenic neuropeptide Y and dynorphin results in paradoxical obesity in mice.
    Nguyen AD; Slack K; Schwarzer C; Lee NJ; Boey D; Macia L; Yulyaningsih E; Enriquez RF; Zhang L; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
    Neuropeptides; 2014 Jun; 48(3):143-51. PubMed ID: 24680736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice.
    Sainsbury A; Lin S; McNamara K; Slack K; Enriquez R; Lee NJ; Boey D; Smythe GA; Schwarzer C; Baldock P; Karl T; Lin EJ; Couzens M; Herzog H
    Mol Endocrinol; 2007 Jul; 21(7):1722-35. PubMed ID: 17456788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.
    Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS
    Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
    Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
    Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis.
    Zhang L; Nguyen AD; Lee IC; Yulyaningsih E; Riepler SJ; Stehrer B; Enriquez RF; Lin S; Shi YC; Baldock PA; Sainsbury A; Herzog H
    Diabetes Obes Metab; 2012 Aug; 14(8):727-36. PubMed ID: 22369253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice.
    Zengin A; Nguyen AD; Wong IP; Zhang L; Enriquez RF; Eisman JA; Herzog H; Baldock PA; Sainsbury A
    Int J Obes (Lond); 2013 Mar; 37(3):390-8. PubMed ID: 22565420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endogenous opioid dynorphin is required for normal bone homeostasis in mice.
    Baldock PA; Driessler F; Lin S; Wong IP; Shi Y; Yulyaningsih E; Castillo L; Janmaat S; Enriquez RF; Zengin A; Kieffer BL; Schwarzer C; Eisman JA; Sainsbury A; Herzog H
    Neuropeptides; 2012 Dec; 46(6):383-94. PubMed ID: 23062312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice.
    Chen H; Vlahos R; Bozinovski S; Jones J; Anderson GP; Morris MJ
    Neuropsychopharmacology; 2005 Apr; 30(4):713-9. PubMed ID: 15508020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting.
    Segal-Lieberman G; Trombly DJ; Juthani V; Wang X; Maratos-Flier E
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1131-9. PubMed ID: 12582011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice.
    Vähätalo LH; Ruohonen ST; Mäkelä S; Kovalainen M; Huotari A; Mäkelä KA; Määttä JA; Miinalainen I; Gilsbach R; Hein L; Ailanen L; Mattila M; Eerola K; Röyttä M; Ruohonen S; Herzig KH; Savontaus E
    Acta Physiol (Oxf); 2015 Apr; 213(4):902-19. PubMed ID: 25482272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38α function in osteoblasts influences adipose tissue homeostasis.
    Rodríguez-Carballo E; Gámez B; Méndez-Lucas A; Sánchez-Freutrie M; Zorzano A; Bartrons R; Alcántara S; Perales JC; Ventura F
    FASEB J; 2015 Apr; 29(4):1414-25. PubMed ID: 25550462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
    Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
    Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of feeding behavior and metabolism by dynorphin.
    Ghule A; Rácz I; Bilkei-Gorzo A; Leidmaa E; Sieburg M; Zimmer A
    Sci Rep; 2020 Mar; 10(1):3821. PubMed ID: 32123224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NPY in hypothalamic mediated food intake.
    Mercer RE; Chee MJ; Colmers WF
    Front Neuroendocrinol; 2011 Oct; 32(4):398-415. PubMed ID: 21726573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
    Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
    Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
    J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis.
    Mashiko S; Moriya R; Ishihara A; Gomori A; Matsushita H; Egashira S; Iwaasa H; Takahashi T; Haga Y; Fukami T; Kanatani A
    Eur J Pharmacol; 2009 Aug; 615(1-3):113-7. PubMed ID: 19482021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPY antagonism reduces adiposity and attenuates age-related imbalance of adipose tissue metabolism.
    Park S; Fujishita C; Komatsu T; Kim SE; Chiba T; Mori R; Shimokawa I
    FASEB J; 2014 Dec; 28(12):5337-48. PubMed ID: 25205743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer.
    Zhang L; Bijker MS; Herzog H
    Pharmacol Ther; 2011 Jul; 131(1):91-113. PubMed ID: 21439311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.